Tenders Are Invited For Eventual and future acquisition of medicines intended for the demands of pharmaceutical care

1 Amphotericin anfotericin , physical aspect in sterile aqueous solution, purity content 250 mcgml, additional characteristic reagent tested in cell culture, chemical reference numer cas 1397893 differentiated treatment: Type I exclusive participation of ME EPPEquipped Applicaility Decree 7174: Non APPLICAILITY PREFERENCE Margin: Non QUANTITY: 500 UPPENDING UNIT: MILYME2 ESILATOACRARY ESILATORY ESILATE, DOSAGE 10 MGML, INJECTAILITY DIFFERENTIATED SOLUTION: : Ampoule 250 ml3 atropine sulfatoatropin sulfate, dosage 050 mgml, use injectale solution Differentiated Treatment: Type I exclusive participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 12500 Supply Unit: Ampolle 100 ml4 iperidenoiperidene, composition hydrochloride , Concentration 5 mgml, pharmaceutical form injectale solution Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non QUANTITY: 4000 Supply Unit: Ampoule 100 ml5 Phenoterol romidratoFenoterol romidrate, Concentration 5 MGML, Pharmaceutical form Oral Treatment Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 10000S Supply Up: Vial 2000 ML